NEW YORK, March 18, 2026, 11:45 EDT
Rocket Lab shares tumbled almost 9% Wednesday, with the stock hitting $71.65 by 11:30 a.m. EDT—off 8.8%—after the company announced plans to sell as much as $1 billion in common stock over time. That move took the momentum out of Tuesday’s 10.2% jump.
That’s notable: Investors had recently sent the stock up, reacting to progress on Neutron and a fresh spotlight on Rocket Lab’s defense business. Injecting new capital might bankroll growth initiatives and possible takeovers, but it brings dilution risk—existing holders could see their ownership trimmed.
This is an at-the-market offering—Rocket Lab can drip shares into the market over time, sidestepping the need for a single big block sale. The company said it may channel proceeds toward growth plans, possible acquisitions, or just general corporate purposes and working capital. Rocket Lab also flagged that it isn’t obligated to tap the entire facility.
The filing laid out the upside scenario, too. If shares held at Monday’s $71.31 close, selling the full $1 billion would mean unloading roughly 14 million shares. Rocket Lab reported 569.4 million shares outstanding as of March 12.
Investors already had plenty on their plates before the filing landed. Back on Feb. 26, Rocket Lab posted a record fourth-quarter revenue figure of roughly $180 million and said full-year revenue came in at $602 million. The backlog – that’s contracted work not yet counted as revenue – jumped 73% to $1.85 billion. “We ended the year with a record $1.85 billion in backlog,” Chief Executive Peter Beck told investors. SEC
Rocket Lab wrapped up 2025 holding $828.7 million in cash, plus roughly $270 million in marketable securities. In that same earnings filing, the company revealed it had acquired Optical Support and Precision Components—moves aimed at boosting its national-security payload offerings and sharpening its precision manufacturing edge.
Neutron remains at the heart of Rocket Lab’s latest wave of optimism. The company is betting the medium-lift rocket can push it past the limits of its smaller Electron rocket. Back in January, Rocket Lab reported a stage-one tank rupture during pressure tests. By February, though, it announced that its “Hungry Hippo” payload fairing and thrust structure for Neutron had cleared qualification. Now, Rocket Lab is aiming for a first Neutron launch sometime in the fourth quarter of 2026. Rocket Lab
Defense contracts keep drawing investors back. Rocket Lab landed an $816 million award from the Space Development Agency, securing a spot with Lockheed Martin, Northrop Grumman, and L3Harris in a $3.5 billion deal for 72 missile-tracking satellites—18 apiece. The agency’s goal: “near-continuous global coverage” for missile warning and tracking. Reuters
The risk remains front and center. Rocket Lab, in its prospectus, flagged that share sales via the new program could put pressure on the stock and cut into earnings per share. The company just logged a $52.9 million net loss in the latest quarter, and its outlook sees an adjusted EBITDA loss — that’s before interest, taxes, and certain non-cash items — anywhere from $21 million to $27 million this quarter. If there’s another setback for Neutron, shareholders face an even longer wait before the larger rocket can start generating revenue.
Wednesday’s decline snapped some of the recent momentum, though not all. After the pullback, shares still managed to hold just above where they closed on Monday.
